Uganda Confirms First Case of Crimean-Congo Hemorrhagic Fever This Year
Kampala, Uganda – Health officials in Uganda have confirmed the country’s first case of Crimean-Congo Hemorrhagic Fever (CCHF) in 2026, raising concerns about a potential outbreak. The case, identified in the Kyankwanzi district, involves a 21-year-ancient male nurse who began experiencing symptoms in mid-January. This development underscores the ongoing risk posed by CCHF in Uganda, a country where the disease is endemic and sporadic outbreaks are linked to tick-borne transmission and livestock exposure. The confirmation comes as public health authorities function to contain the spread and educate communities about preventative measures.
The patient, who also operates a private pharmacy and raises livestock, initially sought care at a local pharmacy before being admitted to St. Peter’s Hospital in the neighboring Kiboga district on February 2nd, according to reports from Xinhua News Agency and the Africa Centres for Disease Control and Prevention (Africa CDC). His symptoms, which developed over several days, included diarrhea, vomiting, loss of appetite, joint pain, conjunctivitis, abdominal pain, chest pain, and unexplained bleeding from the nose and gums. Laboratory tests conducted by the Uganda Virus Research Institute confirmed the diagnosis of CCHF on February 11th, marking the first confirmed case of the year.
Understanding Crimean-Congo Hemorrhagic Fever
Crimean-Congo Hemorrhagic Fever (CCHF) is a widespread tick-borne viral disease. According to the World Health Organization (WHO), it causes severe illness and mortality in affected populations. The virus is transmitted to humans through tick bites or through contact with infected animal blood or tissues during slaughtering or handling of livestock. Human-to-human transmission can also occur through close contact with infected individuals’ blood, secretions, organs, or other bodily fluids. The WHO details the disease’s symptoms, which can include fever, muscle aches, dizziness, neck stiffness, backache, and eventually, hemorrhage.
The disease’s severity varies, with fatality rates ranging from 10% to 40%, according to the WHO. There is no specific treatment for CCHF, and care focuses on supportive measures to manage symptoms and prevent complications. Early diagnosis and appropriate clinical management are crucial for improving patient outcomes.
Uganda’s History with CCHF and Current Response
CCHF is endemic in Uganda, with outbreaks typically occurring in the “cattle corridor” regions of the country, where livestock farming is prevalent. The Africa CDC reported that in 2025, Uganda recorded 17 cases of CCHF, resulting in two fatalities. This latest case in Kyankwanzi district highlights the continued presence of the virus and the need for sustained surveillance and control efforts.
Following the confirmation of the case, Ugandan health authorities have initiated a comprehensive response. Eight contacts of the patient have been identified and are currently under monitoring in both Kyankwanzi and Kiboga districts. Active case finding and alert verification have been activated, and investigations are underway to trace additional contacts and assess the extent of potential exposure. A surveillance team has been deployed to the affected areas to strengthen monitoring and control measures.
The Role of Ticks and Livestock
The transmission of CCHF is closely linked to the presence of ticks and livestock. The virus is maintained in a cycle involving ticks, livestock (such as cattle, sheep, and goats), and wild animals. Humans become infected when bitten by infected ticks or when they come into contact with infected animal blood or tissues. The “cattle corridor” regions of Uganda, characterized by extensive livestock farming, are particularly vulnerable to CCHF outbreaks.
Preventative measures include controlling tick populations on livestock and in the environment, practicing safe animal handling techniques, and avoiding close contact with sick or dead animals. Public awareness campaigns are essential to educate communities about the risks of CCHF and how to protect themselves.
Global Implications and Ongoing Surveillance
While CCHF is primarily concentrated in Africa, the Balkans, and the Middle East, the disease has the potential for international spread through travel and trade. The WHO and other international health organizations closely monitor CCHF outbreaks globally and provide support to affected countries in implementing control measures.
The recent case in Uganda serves as a reminder of the importance of ongoing surveillance and preparedness for CCHF and other emerging infectious diseases. Strengthening laboratory capacity, improving disease detection systems, and enhancing public health infrastructure are crucial for protecting populations from the threat of CCHF and other vector-borne illnesses.
Health officials are urging residents of Kyankwanzi and surrounding areas to remain vigilant and report any suspected cases of CCHF to local health authorities immediately. Early detection and prompt medical care are essential for improving patient outcomes and preventing further spread of the disease.
Key Takeaways
- Uganda has confirmed its first case of Crimean-Congo Hemorrhagic Fever (CCHF) in 2026, in the Kyankwanzi district.
- CCHF is a tick-borne viral disease with a fatality rate ranging from 10% to 40%.
- The disease is endemic in Uganda, with outbreaks linked to livestock exposure and tick bites.
- Health authorities have initiated contact tracing and surveillance measures to contain the spread.
- Preventative measures include tick control, safe animal handling, and public awareness campaigns.
The Ministry of Health in Uganda is expected to provide further updates on the situation as investigations continue. The public is encouraged to stay informed and follow the guidance of health officials to protect themselves and their communities. Continued monitoring and a robust public health response will be critical in mitigating the impact of this outbreak.